Efficacy of TAK-085 in Participants With Hypertriglyceridemia

NCT01350973 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

611

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertriglyceridemia

Interventions

DRUG: Omega-3-acid ethyl esters 90 (TAK-085)
DRUG: Eicosapentaenoic acid-ethyl (EPA-E)

Sponsor

Takeda